Weeks 3 to 8: Wait for and attend obesity-medicine consult
Part of semaglutides success in long-term weight management is how it helps you become more aware of portion sizes to help you establish healthier eating habits to keep the weight off once your treatments end
$50/month copay for eligible GLP-1s, including Wegovy, Zepbound (KwikPen), and the new oral pill Foundayo (orforglipron)*^ Available to Medicare Part D members who meet certain BMI and health criteria* Program runs July 1, 2026 December 31, 2027^ *For eligible Medicare Part D patients with qualifying GLP-1 medication prescription for weight management
Transform your life with medical weight loss solutions at Epiphany Medspa and Wellness
The gastrointestinal effects of semaglutidenausea, bloating, and altered bowel habitsstem primarily from delayed gastric emptying and changes in gut motility rather than from enzyme deficiency
The anti-inflammatory effects are a promising additional benefit, not a primary treatment